Internal surgical staplers made headline news in 2019. Reports discussed the little-known US Food and Drug Administration database housing tens of thousands of stapler-related problem reports and covered the agency’s recent proposal to reclassify staplers as Class II devices, instead of the more lightly regulated Class I.
In perioperative care, high-performing teams are critical to patient safety…
Healthcare has never been static, but today’s perioperative leaders face…
Takeaways • Robot-assisted surgery (RAS) is now an option in…